Company Information:
Feb 06, 2009 | WALTHAM, Mass., Feb 03, 2009 (BUSINESS WIRE) PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, announced the acquisition of Opto Technology, Inc., a leading supplier of light-emitting diode (LED) based lighting components and subsystems.
Jan 30, 2009 | PerkinElmer, Inc. (NYSE: PKI - News), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the fourth quarter ended December 28, 2008. The Company reported GAAP earnings per share from continuing operations of $0.29. On a non-GAAP basis, which includes the adjustments noted in the attached reconciliation, the Company announced adjusted earnings per share of $0.48, which is within the range of the Company's prior guidance.
Nov 18, 2008 | Washington, D.C. - PerkinElmer, Inc., a global leader in life science research, drug discovery and cellular science, today announced the launch of the Volocity� 5 high performance imaging software suite, developed by Improvision, a PerkinElmer company, at the Society for Neuroscience conference.
Sep 16, 2008 | WALTHAM � PerkinElmer, a global leader in life science research, drug discovery and cellular science, today announced the launch of its online radiochemical tool kit, a comprehensive suite of interactive, Web-based applications designed to provide researchers with hands-on access to information they need to support their critical lab requirements. The new online radiochemical tool kit helps customers perform key lab calculations, assists with lab equipment and reagent management, and provides new and more efficient methods for locating key product and technical information.
Sep 16, 2008 | WALTHAM, Mass.(BUSINESS WIRE)Sept. 16, 2008PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008, at 12:30 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
Jul 24, 2008 | WALTHAM, Mass.(BUSINESS WIRE)July 21, 2008PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a one-year agreement with the Mexican Ministry of Health, la Secretaria de Salud, to expand its newborn screening program across Mexico. Under the terms of the agreement, PerkinElmer will provide instrumentation, reagents and screening expertise that will help the Ministry of Health screen for congenital hypothyroidism and triple its screening capacity. The expanded program began in May 2008.
Jul 14, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--July 14, 2008--PerkinElmer, Inc. (NYSE: PKI), a leader in Health Sciences and Photonics, today announced that Alan Fletcher, Ph.D., has joined the Company as vice president, business development for PerkinElmer's Life and Analytical Sciences business. In this role, Fletcher will be responsible for growing the Bio-discovery business through the development of strategic partnerships and alliances in the life science research area, and the introduction of new technologies for GPCR, kinase and biomarker drug target classes.
Jul 08, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--July 7, 2008--PerkinElmer, Inc. (NYSE: PKI), today announced the appointment of Daniel R. Marshak, Ph.D., to the additional position of president of its Greater China operations. In this role, Marshak will assume overall leadership of PerkinElmer in Greater China, and will be responsible for expanding its resources in the region to drive innovation and new product introductions. He will be based out of Shanghai, strengthening the Company's executive and scientific presence in the country. Marshak will continue in his role as senior vice president and chief scientific officer for the Company.
Jul 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--June 30, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced three market-specific LABWORKS(TM) Laboratory Information Management Systems (LIMS) packages that address increasing regulatory and compliance pressures. The new packages are aimed at addressing the critical data management needs of customers in water, food and petrochemical laboratories.
Jun 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--June 12, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it has received top honors in the Life Science Industry Awards for High Throughput Screening (HTS) and Analysis Systems. For the second consecutive year, the Company was named a winner in the Life Science Industry Awards, which are determined based on the input of nearly 4,500 scientists worldwide, and recognize life science companies offering best-in-class technology and service over the past year.
May 23, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--May 19, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Michael L. Battles, the Company's vice president and controller, will lead the finance function on an interim basis, reporting directly to president and chief executive officer, Robert F. Friel. PerkinElmer's current chief financial officer, Jeffrey D. Capello, is resigning to pursue another opportunity outside the Company effective June 6, 2008.
May 18, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--May 15, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the expansion of its health and environmental focus to India with the opening of a new global EcoAnalytix(TM) application and technical center in Mumbai. The EcoAnalytix application and technical center will be dedicated to application development and methods optimization for a range of scientific and industrial laboratory applications, including environmental monitoring, food safety, and sustainable energy.
May 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--April 30, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today announced that it will present at four upcoming financial conferences.
Apr 25, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--April 24, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported financial results for the first quarter ended March 30, 2008. The Company reported GAAP earnings per share from continuing operations of $0.20. On a non-GAAP basis, which includes the adjustments noted in the attached reconciliation, the Company announced adjusted earnings per share of $0.29, which is above the Company's prior guidance of $0.26 to $0.27.
Apr 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--April 14, 2008--PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, April 24, 2008, after market close, the Company will release first quarter 2008 results.
Apr 07, 2008 | Supply and Co-Marketing Agreement Provides Biotechnology and Pharmaceutical Customers with a Total Solution for Drug Candidate Detection and Validation
Apr 07, 2008 | ST. LOUIS--(BUSINESS WIRE)--April 7, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the launch of its VICTOR(TM) X Multilabel Plate Reader platform at the Society for Biomolecular Sciences' (SBS) 14th Annual Conference and Exhibition. The new VICTOR X platform will deliver to customers increased flexibility, while its enhanced versatility will enable support of new applications beyond primary screening, including quality control and therapeutic research.
Mar 26, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 26, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today celebrated the opening of a new Center of Excellence in Singapore. The PerkinElmer Inc. Center of Excellence in Singapore comes as part of PerkinElmer's continued global R&D expansion efforts, and will focus on the development of new precision instrumentation and chemistries for a range of scientific and industrial laboratory applications, including drug discovery and development, environmental monitoring, food safety, and sustainable energy.
Mar 24, 2008 | Distinguished Laboratory Director Joins Company to Drive Quality and Growth in Neonatal and Prenatal Service Business
Mar 24, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 24, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, has announced that it will hold its Annual Meeting of Shareholders on Tuesday, April 22, 2008, at 10:30 a.m. ET at the Company's corporate offices, 940 Winter Street, Waltham, MA.
Mar 20, 2008 | WALTHAM, Mass., Mar 20, 2008 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that it will present at the Bank of America 2008 Small/Mid Cap Conference on Wednesday, March 26, 2008, at 11:20 a.m. Eastern Time at the Four Seasons Hotel in Boston.
Mar 15, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 10, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference on Tuesday, March 18, 2008, at 9:30 a.m. Eastern Time at the Loews Miami Beach Hotel in Miami, Florida.
Mar 15, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 13, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Specimen Gate(R), its specialized information management solution for genetic screening laboratories, has been deployed across more than 70 countries, states and provinces worldwide. The Specimen Gate product portfolio is a critical element of both neonatal and prenatal screening programs, many of which are implemented at the state or national levels of countries around the world, resulting in the identification of thousands of infants at risk of genetic disease each year.
Mar 03, 2008 | NEW ORLEANS-March 3, 2008--PerkinElmer, Inc.(NYSE: PKI), a global leader in health sciences and photonics, today announced that it is showcasing its new EcoAnalytix(TM) initiative at PITTCON(R) 2008, March 2-6, 2008 Booth #2555. EcoAnalytix is PerkinElmer's revolutionary problem-solving initiative that addresses the global imperatives of food and consumer product safety, water quality and sustainable energy development.
Mar 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 29, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced that it has successfully completed its acquisition of the newborn metabolic screening business of Pediatrix Medical Group, Inc. (NYSE: PDX). The completion of this transaction expands PerkinElmer's capabilities in the neonatal health field.
Feb 25, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 25, 2008--PerkinElmer, Inc. (NYSE:PKI), a global technology leader in Health Sciences, today announced that Patrick J. Sullivan, Executive Chairman of Hologic, Inc. (NASDAQ: HOLX), has been elected to the Company's Board of Directors.
Feb 03, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 31, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, 2008, at 4:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
Jan 28, 2008 | WALTHAM, Mass.-Jan. 23, 2008--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), meeting on January 23, 2008, declared a regular quarterly dividend of $.07 per share of common stock. This dividend is payable on May 9, 2008, to all shareholders of record at the close of business on April 18, 2008.
Jan 28, 2008 | WALTHAM, Mass.--Jan. 24, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported financial results for the fourth quarter and fiscal year ended December 30, 2007. For the fourth quarter 2007, the Company reported GAAP earnings per share from continuing operations of $0.46.
Jan 28, 2008 | WALTHAM, Mass.- Jan. 23, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that Robert F. Friel has been elected Chief Executive Officer by the Company's Board of Directors effective February 1, 2008. He will also retain the title of President.
Jan 16, 2008 | WALTHAM, Mass. � PerkinElmer Life and Analytical Sciences, a global leader in life science research, drug discovery and cellular science, today announced the launch of the new WIZARD2� Automated Gamma Counter.
Jan 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 16, 2008--PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, January 24, 2008, after market close, the Company will release fourth quarter 2007 results.
Jan 04, 2008 | WALTHAM, Mass., Dec 31, 2007- PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the JPMorgan Healthcare Conference on Tuesday, January 8, 2008, at 11:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco.
Dec 27, 2007 | WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 19, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced the signing of a definitive agreement with Pediatrix Medical Group, Inc. (NYSE: PDX) under which PerkinElmer will acquire the newborn metabolic screening business of Pediatrix in a cash transaction.
Dec 13, 2007 | WALTHAM, Mass., Dec 12, 2007, PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced it has received additional production orders for mobile phone flash assemblies incorporating its Xenon-based flash technology.
Nov 15, 2007 | WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 15, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced that it has successfully completed its acquisition of ViaCell, Inc., a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells.
Nov 12, 2007 | WALTHAM & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 9, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced the successful completion of its tender offer to acquire all outstanding shares of common stock of ViaCell, Inc. (Nasdaq: VIAC), at a price of $7.25 per share, in cash.
Nov 05, 2007 | New UltraVIEW(R) VoX System Integrates Confocal Microscopy and Software Technologies for High-Speed, High-Quality Cell Imaging and Analysis
Nov 04, 2007 | NEW YORK, Nov 02, 2007 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI) today announced the availability of a webcast replay of its 2007 Analyst Meeting, held Friday, November 2, 2007, at the Millennium Broadway Hotel in New York City.
Oct 26, 2007 | WALTHAM, Mass. & CAMBRIDGE, Mass.-Oct. 25, 2007-PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, as amended, expired on October 24, 2007, with respect to its tender offer for ViaCell, Inc. (Nasdaq: VIAC).
Oct 26, 2007 | WALTHAM, Mass.-Oct. 25, 2007-PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported financial results for the third quarter and nine months ended September 30, 2007. For the third quarter 2007, the Company reported GAAP earnings per share from continuing operations of $0.26.
Oct 18, 2007 | BEIJING-Oct. 17, 2007-PerkinElmer, Inc. (NYSE: PKI) a global technology leader in Health Sciences, today unveiled EcoAnalytix(TM), a revolutionary problem-solving initiative that addresses the global imperatives of food safety, water quality and biofuels development.
Oct 12, 2007 | WALTHAM & CAMBRIDGE, Mass.-Oct. 12, 2007-On October 12, 2007, Victor Acquisition Corp., an indirect wholly owned subsidiary of PerkinElmer, Inc. (NYSE: PKI), commenced a tender offer to acquire all outstanding shares of common stock of ViaCell, Inc. (Nasdaq: VIAC), at a price of $7.25 per share, in cash, pursuant to a previously announced Agreement and Plan of Merger among PerkinElmer, Inc., Victor Acquisition Corp. and ViaCell, Inc., dated October 1, 2007.
Oct 11, 2007 | WALTHAM, Mass.-Oct. 11, 2007-PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today announced a complete analytical solution for the determination of melamine adulteration in protein-based foods. With the release of the Melamine Analyzer, based on the innovative Clarus(R) 600 T Gas Chromatograph/Mass Spectrometer (GC/MS), PerkinElmer is the first in the industry to provide such solution using GC/MS technology.
Oct 09, 2007 | SEOUL, South Korea--(BUSINESS WIRE)--Oct. 8, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, dramatically strengthens its portfolio of protein analysis and imaging technologies with the introduction of five new products at the Human Proteome Organization's (HUPO) 6th Annual World Congress in Seoul, South Korea, Oct. 6-10.
Oct 05, 2007 | WALTHAM, Mass-Oct. 5, 2007-PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, October 25, 2007, after market close, the Company will release third quarter 2007 results.
Oct 02, 2007 | WALTHAM, Mass. & CAMBRIDGE, Mass. -Oct. 1, 2007- PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, and ViaCell, Inc. (Nasdaq: VIAC), a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells, announced today the signing of a definitive agreement under which PerkinElmer plans to acquire ViaCell.
Oct 01, 2007 | SANTA CLARA, Calif.-Sept. 28, 2007-PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the expansion of its Santa Clara, California, digital x-ray detector fabrication facility. The 80,000-square foot facility produces amorphous silicon digital x-ray detector panels for use in radiography, angiography, cardiovascular imaging, and radiation oncology.
Sep 18, 2007 | WALTHAM, Mass. -Sept. 18, 2007 - PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 24, 2007, at 4:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
Sep 13, 2007 | WALTHAM, Mass.-- Sept. 12, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, announced that it will host an Analyst Meeting on Friday, November 2, 2007, starting at 9:00 a.m. Eastern Time at the Millennium Broadway Hotel in New York City.